Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
- Frandsen CS, Dejgaard TF, Holst JJ, et al. Twelve-Week Treatment With Liraglutide As Add-On to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blinded Parallel Study [published online ahead of print October 20, 2015]. Diabetes Care. doi: 10.2337/dc15-1037.
- Henry RR, Thakkar P, Tong C, et al. Efficacy and Safety of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, as Add-On to Insulin in Patients With Type 1 Diabetes [published online ahead of print October 20, 2015]. Diabetes Care. doi: 10.2337/dc15-1730.
Disclosure statements are available on the authors' profiles: